Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression

Cancer Res. 2009 Dec 15;69(24):9448-56. doi: 10.1158/0008-5472.CAN-09-1903.

Abstract

By using LNCaP and its derivative cell lines, we first observed an association between tumor necrosis factor-alpha (TNF-alpha) resistance and hormone independence. Moreover, we found that the expression of tumor necrosis factor receptor-associated death domain (TRADD) was reduced in androgen deprivation-independent cells compared with that in androgen deprivation-dependent cells. TRADD is a crucial transducer for TNF-alpha-induced nuclear factor-kappaB (NF-kappaB) activation. Knocking down TRADD expression in LNCaP cells impaired TNF-alpha-induced NF-kappaB activation and androgen receptor repression, whereas overexpression of TRADD in C4-2B cells restored their sensitivity to TNF-alpha. Finally, we found that androgen deprivation reduces TRADD expression in vitro and in vivo, suggesting that androgen deprivation therapy may promote the development of TNF-alpha resistance by reducing TRADD expression during prostate cancer progression.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Androgen Receptor Antagonists
  • Androgens / deficiency
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Disease Progression
  • Humans
  • Male
  • Middle Aged
  • NF-kappa B / metabolism
  • Neoplasms, Hormone-Dependent / genetics
  • Neoplasms, Hormone-Dependent / metabolism
  • Neoplasms, Hormone-Dependent / pathology
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology
  • Receptors, Androgen / metabolism
  • TNF Receptor-Associated Death Domain Protein / biosynthesis*
  • TNF Receptor-Associated Death Domain Protein / genetics
  • Transfection
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Androgen Receptor Antagonists
  • Androgens
  • NF-kappa B
  • Receptors, Androgen
  • TNF Receptor-Associated Death Domain Protein
  • Tumor Necrosis Factor-alpha